• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Novo nixes trial of blood pressure drug it bought in deal worth $1.3B

    BIOPHARMADIVE

    Novo stops the ocedurenone CLARION-CKD trial and recognises impairment loss

    GLOBENEWSWIRE

    Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP Bio

    GLOBENEWSWIRE

    Novo Nordisk in $1.3 bln deal to buy hypertension drug

    REUTERS

    Ocedurenone: A Novel Therapy for Uncontrolled Hypertension in Advanced CKD

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.